Macon GA 克罗恩病临床试验
5项针对 克罗恩病的研究正在 Macon及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- Gastroenterology Associates of Central Georgia ( Site 5048), Macon
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Gastroenterology Associates of Central Georgia /ID# 280464, Macon
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- Gastroenterology Associates of Central Georgia /ID# 265547, Macon
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Gastroenterology Associates of Central GA, Macon
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
招募中2/3 期
- Gastroenterolgy Associates of Central GA, Macon
其他城市的 克罗恩病试验
- New York City, NY35 项研究
- Cleveland, OH19 项研究
- St. Louis, MO19 项研究
- Boston, MA19 项研究
- Miami, FL19 项研究
- Orlando, FL17 项研究
- Houston, TX17 项研究
- Atlanta, GA17 项研究
- Tyler, TX16 项研究
- San Diego, CA15 项研究
- San Antonio, TX15 项研究
- Los Angeles, CA15 项研究
Macon的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。